A pioneer among foreign companies in Japan, Sceti Co., Ltd. was established in Tokyo in 1925. It was then integrated into the Denis Group in 1958. In its early years, the company served as an agent for major French heavy industry companies. Sceti Co., Ltd. then gradually increased its involvement in nuclear medicine, strengthening its portfolio in quantum equipment, isotopes, reagents and diagnostics. Meanwhile, it diversified its operations, heading into the field of Life Science by importing advanced functional ingredients for foodstuffs, health food, cosmetics, and pharmaceutical manufacturing. In recent years, the company has ventured into the field of diagnostic imaging, supplying high performance systems, equipment, and related services used in medical diagnosis and treatment. In 2006, Sceti Co., Ltd. made a major investment in radiopharmaceuticals. This was achieved through the incorporation of Denis Pharma K.K.,formerly Sceti Medical Labo K.K., which imports, manufactures, and distributes innovative biomarkers. The incorporation was undertaken as a joint venture with Ion Beam Applications S.A. (IBA). Only a few short years later, Denis Pharma K.K.,formerly Sceti Medical Labo K.K., has become a major domestic player in the fields of RIA diagnostics and pharmaceutical drug screening solutions.
In 2009, Sceti K.K. and Yuai Clinic (Shin-Yokohama), the largest PET diagnostic center in Japan built up a good relationship and works as a close partner.
In 2011, Sceti Medical (Asia) Pte., Ltd. was established in Singapore and Malaysia to link together networks in Japan and ASEAN countries within the field of medical imaging.Today, the Health Science activities of Denis Japan are represented by the SCETI GROUP of companies, and markets innovative solutions focusing on the life science, medical and bio-medical fields. It works as importer, distributor, licensor and manufacturer operating under QMS compliance, serving the industrial, medical, clinical, pharmaceutical, and research networks in Japan, ASEAN countries, and export markets.
